ACTA1 and neoplasm: Importantly, this compound also decreased the tumor growth (measured by bioluminescence in vivo) in an orthotopic xenograft mouse model of PDAC, reduced the number of activated PSCs (seen as decreased α-SMA expression) as well as inhibited collagen deposition [223].